Evaluation of Age-related Macular Degeneration With Optical Coherence Tomography

Survey of Ophthalmology

Volumn 57, Issue 5, 2012, Pages 389-414

  Keane, Pearse A ^a,b   Patel, Praveen J ^a   Liakopoulos, Sandra ^c   Heussen, Florian M ^b,d   Sadda, Srinivas R ^b   Tufail, Adnan ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF COLOGNE   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Cystoid macular edema; Drusen; Geographic atrophy; Optical coherence tomography; Pigment epithelium detachment; Polypoidal choroidal vasculopathy; Retinal angiomatous proliferation; Subretinal fluid

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB;

AGE RELATED CHOROIDAL ATROPHY; B SCAN; CHOROID DISEASE; DRUSEN; EYE FUNDUS; EYE TRACKING; GEOGRAPHIC ATROPHY; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE PROCESSING; IMAGING SYSTEM; INTRARETINAL FLUID; OPTICAL COHERENCE TOMOGRAPHY; PHASE 3 CLINICAL TRIAL (TOPIC); PIGMENT EPITHELIUM; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RADIODIAGNOSTIC EQUIPMENT AND SUPPLIES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA DETACHMENT; RETINA DISEASE; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; RETINA TEAR; RETINAL ANGIOMATOUS PROLIFERATION; REVIEW; RISK FACTOR; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VITREOUS DISEASE;

ANGIOGENESIS INHIBITORS; CHOROIDAL NEOVASCULARIZATION; GEOGRAPHIC ATROPHY; HUMANS; MACULAR DEGENERATION; MACULAR EDEMA; RETINAL DETACHMENT; RETINAL DRUSEN; RETINAL PIGMENT EPITHELIUM; SUBRETINAL FLUID; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84865157285     PISSN: 00396257     EISSN: 18793304     Source Type: Journal    
DOI: 10.1016/j.survophthal.2012.01.006     Document Type: Review

References (262)

1. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular Photocoagulation Study Group. Arch Ophthalmol 1991, 109:1242-1257.
2. Abe S., Yamamoto T., Haneda S., et al. Three-dimensional features of polypoidal choroidal vasculopathy observed by spectral-domain OCT. Ophthalmic Surg Lasers Imaging 2010, 1-6.
3. Ahlers C., Golbaz I., Einwallner E., et al. Identification of optical density ratios in subretinal fluid as a clinically relevant biomarker in exudative macular disease. Invest Ophthalmol Vis Sci 2009, 50:3417-3424.
4. Ahlers C., Golbaz I., Stock G., et al. Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration. Ophthalmology 2008, 115:e39-e46.
5. Ahlers C., Götzinger E., Pircher M., et al. Imaging of the retinal pigment epithelium in age-related macular degeneration using polarization-sensitive optical coherence tomography. Invest Ophthalmol Vis Sci 2010, 51:2149-2157.
6. Ahlers C., Michels S., Elsner H., et al. Topographic angiography and optical coherence tomography: a correlation of imaging characteristics. Eur J Ophthalmol 2005, 15:774-781.
7. Ahlers C., Simader C., Geitzenauer W., et al. Automatic segmentation in three-dimensional analysis of fibrovascular pigmentepithelial detachment using high-definition optical coherence tomography. Br J Ophthalmol 2008, 92:197-203.
8. Aisenbrey S., Gelisken F., Szurman P., et al. Surgical treatment of peripapillary choroidal neovascularisation. Br J Ophthalmol 2007, 91:1027-1030.
9. Ambati J., Ambati B.K., Yoo S.H., et al. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003, 48:257-293.
10. Amoaku W. Ranibizumab: the clinician's guide to commencing, continuing, and discontinuing treatment. Eye 2009, 23:2140-2142.
11. Amoaku W. The Royal College of Ophthalmologists interim recommendations for the management of patients with age-related macular degeneration. Eye 2008, 22:864-868.
12. Arnold J.J., Sarks S.H., Killingsworth M.C., et al. Reticular pseudodrusen. A risk factor in age-related maculopathy. Retina 1995, 15:183-191.
13. Barbazetto I., Burdan A., Bressler N.M., et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2. Arch Ophthalmol 2003, 121:1253-1268.
14. Bearelly S., Chau F., Koreishi A., et al. Spectral domain optical coherence tomography imaging of geographic atrophy margins. Ophthalmology 2009, 116:1762-1769.
15. Binder S. Surgical treatment of peripapillary choroidal neovascularisation. Br J Ophthalmol 2007, 91:990-991.
16. Bird A.C., Bressler N.M., Bressler S.B., et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995, 39:367-374.
17. Bloom S.M., Singal I.P. The outer Bruch membrane layer: a previously undescribed spectral-domain optical coherence tomography finding. Retina 2011, 31:316-323.
18. Bolz M., Schmidt-Erfurth U., Deak G., et al. Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology 2009, 116:914-920.
19. Brar M., Bartsch D.U., Nigam N., et al. Colour versus greyscale display of images on high-resolution spectral OCT. Br J Ophthalmol 2009, 93:597-602.
20. Brar M., Kozak I., Cheng L., et al. Correlation between spectral-domain optical coherence tomography and fundus autofluorescence at the margins of geographic atrophy. Am J Ophthalmol 2009, 148:439-444.
21. Bressler N.M. Age-related macular degeneration is the leading cause of blindness. JAMA 2004, 291:1900-1901.
22. Bressler N.M. Antiangiogenic approaches to age-related macular degeneration today. Ophthalmology 2009, 116:S15-S23.
23. Bressler N.M., Bressler S.B., Alexander J., et al. Loculated fluid. A previously undescribed fluorescein angiographic finding in choroidal neovascularization associated with macular degeneration. Macular Photocoagulation Study Reading Center. Arch Ophthalmol 1991, 109:211-215.
24. Bressler N.M., Bressler S.B., West S.K., et al. The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol 1989, 107:847-852.
25. Brown D.M., Kaiser P.K., Michels M., et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006, 355:1432-1444.
26. Brown D.M., Regillo C.D. Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol 2007, 144:627-637.
27. Chan C.K., Abraham P., Meyer C.H., et al. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections. Retina 2010, 30:203-211.
28. Chang L.K., Fine H.F., Spaide R.F., et al. Ultrastructural correlation of spectral-domain optical coherence tomographic findings in vitreomacular traction syndrome. Am J Ophthalmol 2008, 146:121-127.
29. Chang L.K., Sarraf D. Tears of the retinal pigment epithelium: an old problem in a new era. Retina 2007, 27:523-534.
30. Chen T.C., Cense B., Pierce M.C., et al. Spectral domain optical coherence tomography: ultra-high speed, ultra-high resolution ophthalmic imaging. Arch Ophthalmol 2005, 123:1715-1720.
31. Chiang A., Chang L., Yu F., et al. Predictors of anti-VEGF-associated retinal pigment epithelial tear using FA and OCT analysis. Retina 2008, 28:1265-1269.
32. Choma M.A., Hsu K., Izatt J.A. Swept source optical coherence tomography using an all-fiber 1300-nm ring laser source. J Biomed Opt 2005, 10:44009.
33. Choma M.A., Sarunic M.V., Yang C.H., et al. Sensitivity advantage of swept source and Fourier domain optical coherence tomography. Opt Express 2003, 11:2183-2189.
34. Ciardella A.P., Donsoff I.M., Huang S.J., et al. Polypoidal choroidal vasculopathy. Surv Ophthalmol 2004, 49:25-37.
35. Cohen S.Y., Dubois L., Nghiem-Buffet S., et al. Retinal pseudocysts in age-related geographic atrophy. Am J Ophthalmol 2010, 150:211-217.
36. Cohen S.Y., Dubois L., Tadayoni R., et al. Prevalence of reticular pseudodrusen in age-related macular degeneration with newly diagnosed choroidal neovascularisation. Br J Ophthalmol 2007, 91:354-359.
37. Coscas F., Coscas G., Souied E., et al. Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 2007, 144:592-599.
38. Costa R.A., Calucci D., Paccola L., et al. Occult chorioretinal anastomosis in age-related macular degeneration: a prospective study by optical coherence tomography. Am J Ophthalmol 2005, 140:107-116.
39. Costa R.A., Navajas E.V., Farah M.E., et al. Polypoidal choroidal vasculopathy: angiographic characterization of the network vascular elements and a new treatment paradigm. Prog Retin Eye Res 2005, 24:560-586.
40. Curcio C.A., Medeiros N.E., Millican C.L. Photoreceptor loss in age-related macular degeneration. Invest Ophthalmol Vis Sci 1996, 37:1236-1249.
41. Davis M.D., Gangnon R.E., Lee L.-Y., et al. The Age-related Eye Disease Study severity scale for age-related macular degeneration: AREDS report no. 17. Arch Ophthalmol 2005, 123:1484-1498.
42. de Jong P.T.V.M. Age-related macular degeneration. N Engl J Med 2006, 355:1474-1485.
43. Gass J.D.M. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment, vol. 1 1997, Mosby, St Louis, MO, ed 4.
44. Drexler W., Fujimoto J.G. State-of-the-art retinal optical coherence tomography. Prog Retin Eye Res 2008, 27:45-88.
45. Engelbert M., Zweifel S.A., Freund K.B. Long-term follow-up for type 1 (subretinal pigment epithelium) neovascularization using a modified " treat and extend" dosing regimen of intravitreal antivascular endothelial growth factor therapy. Retina 2010, 30:1368-1375.
46. Engelbert M., Zweifel S.A., Freund K.B. " Treat and extend" dosing of intravitreal antivascular endothelial growth factor therapy for type 3 neovascularization/retinal angiomatous proliferation. Retina 2009, 29:1424-1431.
47. Eriksson U., Alm A., Larsson E. Is quantitative spectral-domain superior to time-domain optical coherence tomography (OCT) in eyes with age-related macular degeneration?. Acta Ophthalmol 2011, [Epub ahead of print].
48. Esmaeelpour M., Povazay B., Hermann B., et al. Three-dimensional 1060nm OCT: choroidal thickness maps in normals and improved posterior segment visualization in cataract patients. Invest Ophthalmol Vis Sci 2010, 51:5260-5266.
49. Ferguson R.D., Hammer D.X., Paunescu L.A., et al. Tracking optical coherence tomography. Opt Lett 2004, 29:2139-2141.
50. Fernández E.J., Hermann B., Povazay B., et al. Ultrahigh resolution optical coherence tomography and pancorrection for cellular imaging of the living human retina. Optics Express 2008, 16:11083-11094.
51. Figueroa M.S., Noval S., Contreras I. Treatment of peripapillary choroidal neovascular membranes with intravitreal bevacizumab. Br J Ophthalmol 2008, 92:1244-1247.
52. Finger R.P., Issa P.C., Kellner U., et al. Spectral domain optical coherence tomography in adult-onset vitelliform macular dystrophy with cuticular drusen. Retina 2010, 30:1455-1464.
53. Fleckenstein M., Charbel Issa P., Helb H.-M., et al. High-resolution spectral domain OCT imaging in geographic atrophy associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 2008, 49:4137-4144.
54. Fleckenstein M., Schmitz-Valckenberg S., Adrion C., et al. Tracking progression with spectral-domain optical coherence tomography in geographic atrophy caused by age-related macular degeneration. Invest Ophthalmol Vis Sci 2010, 51:3846-3852.
55. Fleckenstein M., Schmitz-Valckenberg S., Martens C., et al. Fundus autofluorescence and spectral domain optical coherence tomography characteristics in a rapidly progressing form of geographic atrophy. Invest Ophthalmol Vis Sci 2011, 52:3761-3766.
56. Fleckenstein M., Wolf-Schnurrbusch U., Wolf S., et al. [Imaging diagostics of geographic atrophy.]. Der Ophthalmologe 2010, 107:1007-1015.
57. Framme C., Panagakis G., Birngruber R. Effects on choroidal neovascularization after anti-VEGF upload using intravitreal ranibizumab, as determined by spectral domain-optical coherence tomography. Invest Ophthalmol Vis Sci 2010, 51:1671-1676.
58. Framme C., Panagakis G., Walter A., et al. Interobserver variability for retreatment indications after ranibizumab loading doses in neovascular age-related macular degeneration. Acta Ophthalmol 2012, 90:49-55.
59. Freeman S.R., Kozak I., Cheng L., et al. Optical coherence tomography-raster scanning and manual segmentation in determining drusen volume in age-related macular degeneration. Retina 2010, 30:431-435.
60. Freund K.B., Ho I.V., Barbazetto I.A., et al. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina 2008, 28:201-211.
61. Freund K.B., Laud K., Lima L.H., et al. Acquired vitelliform lesions: correlation of clinical findings and multiple imaging analyses. Retina 2011, 31:13-25.
62. Freund K.B., Zweifel S.A., Engelbert M. Do we need a new classification for choroidal neovascularization in age-related macular degeneration?. Retina 2011, 30:1333-1349.
63. Fujiwara T., Imamura Y., Margolis R., et al. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol 2009, 148:445-450.
64. Fung A.E., Lalwani G.A., Rosenfeld P.J., et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007, 143:566-583.
65. Gass J.D. A clinicopathologic study of a peculiar foveomacular dystrophy. Trans Am Ophthalmol Soc 1974, 72:139-156.
66. Gass J.D., Jallow S., Davis B. Adult vitelliform macular detachment occurring in patients with basal laminar drusen. Am J Ophthalmol 1985, 99:445-459.
67. Gass J.D.M., Agarwal A., Lavina A.M., et al. Focal inner retinal hemorrhages in patients with drusen: an early sign of occult choroidal neovascularization and chorioretinal anastomosis. Retina 2003, 23:741-751.
68. Ghazi N.G., Kirk T., Allam S., et al. Quantification of error in optical coherence tomography central macular thickness measurement in wet age-related macular degeneration. Am J Ophthalmol 2009, 148:90-96.
69. Giani A., Cigada M., Esmaili D.D., et al. Artifacts in automatic retinal segmentation using different optical coherence tomography instruments. Retina 2010, 30:607-616.
70. Giani A., Esmaili D.D., Luiselli C., et al. Displayed reflectivity of choroidal neovascular membranes by optical coherence tomography correlates with presence of leakage by fluorescein angiography. Retina 2011, 31:942-948.
71. Giovannini A., Amato G., Mariotti C., et al. Optical coherence tomography in the assessment of retinal pigment epithelial tear. Retina 2000, 20:37-40.
72. Gloesmann M., Hermann B., Schubert C., et al. Histologic correlation of pig retina radial stratification with ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci 2003, 44:1696-1703.
73. Gorczynska I., Srinivasan V.J., Vuong L.N., et al. Projection OCT fundus imaging for visualising outer retinal pathology in non-exudative age-related macular degeneration. Br J Ophthalmol 2009, 93:603-609.
74. Green W.R. Clinicopathologic studies of treated choroidal neovascular membranes. A review and report of two cases. Retina 1991, 11:328-356.
75. Green W.R. Histopathology of age-related macular degeneration. Mol Vis 1999, 5:27.
76. Green W.R., Enger C. Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology 1993, 100:1519-1535.
77. Green W.R., Gass J.D. Senile disciform degeneration of the macula. Retinal arterialization of the fibrous plaque demonstrated clinically and histopathologically. Arch Ophthalmol 1971, 86:487-494.
78. Green W.R., McDonnell P.J., Yeo J.H. Pathologic features of senile macular degeneration. Ophthalmology 1985, 92:615-627.
79. Gregori G., Wang F., Rosenfeld P.J., et al. Spectral domain optical coherence tomography imaging of drusen in nonexudative age-related macular degeneration. Ophthalmology 2011, 118:1373-1379.
80. Grossniklaus H.E., Cingle K.A., Yoon Y.D., et al. Correlation of histologic 2-dimensional reconstruction and confocal scanning laser microscopic imaging of choroidal neovascularization in eyes with age-related maculopathy. Arch Ophthalmol 2000, 118:625-629.
81. Grossniklaus H.E., Gass J.D. Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes. Am J Ophthalmol 1998, 126:59-69.
82. Grossniklaus H.E., Green W.R. Choroidal neovascularization. Am J Ophthalmol 2004, 137:496-503.
83. Gupta O.P., Shienbaum G., Patel A.H., et al. A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact. Ophthalmology 2010, 117:2134-2140.
84. Hamel C.P., Meunier I., Arndt C., et al. Extensive macular atrophy with pseudodrusen-like appearance: a new clinical entity. Am J Ophthalmol 2009, 147:609-620.
85. Han IC, Jaffe GJ. Evaluation of artifacts associated with macular spectral-domain optical coherence tomography. Ophthalmology. 117:1177-89.
86. Harding S.P. Neovascular age-related macular degeneration: decision making and optimal management. Eye 2010, 24:497-505.
87. Hayashi H., Yamashiro K., Tsujikawa A., et al. Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration. Am J Ophthalmol 2009, 148:83-89.
88. Hee M.R., Baumal C.R., Puliafito C.A., et al. Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology 1996, 103:1260-1270.
89. Hee M.R., Puliafito C.A., Duker J.S., et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 1998, 105:360-370.
90. Hee M.R., Puliafito C.A., Wong C., et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol 1995, 113:1019-1029.
91. Helb H.M., Charbel Issa P., Fleckenstein M., et al. Clinical evaluation of simultaneous confocal scanning laser ophthalmoscopy imaging combined with high-resolution, spectral-domain optical coherence tomography. Acta Ophthalmol 2010, 88:842-849.
92. Ho J., Witkin A.J., Liu J., et al. Documentation of intraretinal retinal pigment epithelium migration via high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology 2011, 118:687-693.
93. Hogg R.E., Chakravarthy U. Visual function and dysfunction in early and late age-related maculopathy. Prog Retin Eye Res 2006, 25:249-276.
94. Holz F.G., Pauleikhoff D., Klein R., et al. Pathogenesis of lesions in late age-related macular disease. Am J Ophthalmol 2004, 137:504-510.
95. Hoskin A., Bird A.C., Sehmi K. Tears of detached retinal pigment epithelium. Br J Ophthalmol 1981, 65:417-422.
96. Huang D., Swanson E.A., Lin C.P., et al. Optical coherence tomography. Science 1991, 254:1178-1181.
97. Iida T., Yannuzzi L.A., Spaide R.F., et al. Cystoid macular degeneration in chronic central serous chorioretinopathy. Retina 2003, 23:1-7.
98. Iijima H., Iida T., Imai M., et al. Optical coherence tomography of orange-red subretinal lesions in eyes with idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 2000, 129:21-26.
99. Iijima H., Imai M., Gohdo T., et al. Optical coherence tomography of idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 1999, 127:301-305.
100. Imamura Y., Fujiwara T., Margolis R., et al. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 2009, 29:1469-1473.
101. Imamura Y., Iida T., Maruko I., et al. Enhanced depth imaging optical coherence tomography of the sclera in dome-shaped macula. Am J Ophthalmol 2011, 151:297-302.
102. Ip L.P., Nguyen T.Q., Bartsch D.U. Fundus based eye tracker for optical coherence tomography. Conf Proc IEEE Eng Med Biol Soc 2004, 2:1505-1508.
103. Jager R.D., Mieler W.F., Miller J.W. Age-related macular degeneration. N Engl J Med 2008, 358:2606-2617.
104. Joeres S., Kaplowitz K., Brubaker J.W., et al. Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration. Ophthalmology 2008, 115:347-354.
105. Joeres S., Tsong J.W., Updike P.G., et al. Reproducibility of quantitative optical coherence tomography subanalysis in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2007, 48:4300-4307.
106. Johnson P.T., Lewis G.P., Talaga K.C., et al. Drusen-associated degeneration in the retina. Invest Ophthalmol Vis Sci 2003, 44:4481-4488.
107. Jun J.J., Duker J.S., Baumal C.R., et al. Cystoid macular edema without macular thickening: a retrospective optical coherence tomographic study. Retina 2010, 30:917-923.
108. Jutley G., Tah V., Lindfield D., et al. Treating peripapillary choroidal neovascular membranes: a review of the evidence. Eye 2011, 25:675-681.
109. Kaiser P.K., Blodi B.A., Shapiro H., et al. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 2007, 114:1868-1875.
110. Karam E.Z., Ramirez E., Arreaza P.L., et al. Optical coherence tomographic artefacts in diseases of the retinal pigment epithelium. Br J Ophthalmol 2007, 91:1139-1142.
111. Kashani A.H., Keane P.A., Dustin L., et al. Quantitative subanalysis of cystoid spaces and outer nuclear layer using optical coherence tomography in age-related macular degeneration. Invest Ophthalmol Vis Sci 2009, 50:3366-3373.
112. Keane P. Spectral domain optical coherence tomography. Saudi J Ophthalmol 2008, 22:231-239.
113. Keane P.A., Aghaian E., Ouyang Y., et al. Acute severe visual decrease after photodynamic therapy with verteporfin: spectral-domain OCT features. Ophthalmic Surg Lasers Imaging 2010, 41:S85-S88.
114. Keane P.A., Bhatti R.A., Brubaker J.W., et al. Comparison of clinically relevant findings from high-speed fourier-domain and conventional time-domain optical coherence tomography. Am J Ophthalmol 2009, 148:242-248.
115. Keane P.A., Chang K.T., Liakopoulos S., et al. Effect of ranibizumab retreatment frequency on neurosensory retinal volume in neovascular AMD. Retina 2009, 29:592-600.
116. Keane P.A., Liakopoulos S., Chang K.T., et al. Comparison of the optical coherence tomographic features of choroidal neovascular membranes in pathological myopia versus age-related macular degeneration, using quantitative subanalysis. Br J Ophthalmol 2008, 92:1081-1085.
117. Keane P.A., Liakopoulos S., Chang K.T., et al. Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. Ophthalmology 2008, 115:2206-2214.
118. Keane P.A., Liakopoulos S., Jivrajka R.V., et al. Evaluation of optical coherence tomography retinal thickness parameters for use in clinical trials for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2009, 50:3378-3385.
119. Keane P.A., Liakopoulos S., Ongchin S.C., et al. Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2008, 49:3115-3120.
120. Keane P.A., Liakopoulos S., Walsh A.C., et al. Limits of the retinal-mapping program in age-related macular degeneration. Br J Ophthalmol 2009, 93:274-275.
121. Keane P.A., Mand P.S., Liakopoulos S., et al. Accuracy of retinal thickness measurements obtained with Cirrus optical coherence tomography. Br J Ophthalmol 2009, 93:1461-1467.
122. Keane P.A., Patel P.J., Ouyang Y., et al. Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2010, 51:5431-5437.
123. Keane P.A., Sadda S.R. Imaging chorioretinal vascular disease. Eye 2010, 24:422-427.
124. Keane P.A., Sadda S.R. Optical coherence tomography in the diagnosis and management of diabetic retinopathy. Int Ophthalmol Clin 2009, 49:61-74.
125. Khanifar A., Koreishi A., Izatt J., et al. Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration. Ophthalmology 2008, 115:1883-1890.
126. Khurana R.N., Dupas B., Bressler N.M. Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal neovascularization. Ophthalmology 2010, 117:1376-1380.
127. Kiernan D.F., Mieler W.F., Hariprasad S.M. Spectral-domain optical coherence tomography: a comparison of modern high-resolution retinal imaging systems. Am J Ophthalmol 2010, 149:18-31.
128. Kiss C.G., Geitzenauer W., Simader C., et al. Evaluation of ranibizumab-induced changes in high-resolution optical coherence tomographic retinal morphology and their impact on visual function. Invest Ophthalmol Vis Sci 2009, 50:2376-2383.
129. Klein R., Davis M.D., Magli Y.L., et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991, 98:1128-1134.
130. Klein R., Meuer S.M., Knudtson M.D., et al. The epidemiology of retinal reticular drusen. Am J Ophthalmol 2008, 145:317-326.
131. Kleiner R.C., Brucker A.J., Johnston R.L. The posterior uveal bleeding syndrome. Retina 1990, 10:9-17.
132. Koizumi H., Spaide R.F., Fisher Y.L., et al. Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Am J Ophthalmol 2008, 145:509-517.
133. Kramer M., Mimouni K., Priel E., et al. Comparison of fluorescein angiography and indocyanine green angiography for imaging of choroidal neovascularization in hemorrhagic age-related macular degeneration. Am J Ophthalmol 2000, 129:495-500.
134. Krebs I., Ansari-Shahrezaei S., Goll A., et al. Activity of neovascular lesions treated with bevacizumab: comparison between optical coherence tomography and fluorescein angiography. Graefes Arch Clin Exp Ophthalmol 2008, 246:811-815.
135. Krebs I., Brannath W., Glittenberg C., et al. Posterior vitreomacular adhesion: a potential risk factor for exudative age-related macular degeneration?. Am J Ophthalmol 2007, 144:741-746.
136. Krebs I., Falkner-Radler C., Hagen S., et al. Quality of the threshold algorithm in age-related macular degeneration: Stratus versus Cirrus OCT. Invest Ophthalmol Vis Sci 2009, 50:995-1000.
137. Krebs I., Glittenberg C., Hagen S., et al. Retinal angiomatous proliferation: morphological changes assessed by Stratus and Cirrus OCT. Ophthalmic Surg Lasers Imaging 2009, 40:285-289.
138. Krebs I., Glittenberg C., Zeiler F., et al. Spectral domain optical coherence tomography for higher precision in the evaluation of vitreoretinal adhesions in exudative age-related macular degeneration. Br J Ophthalmol 2011, 95:1415-1418.
139. Krebs I., Haas P., Zeiler F., et al. Optical coherence tomography: limits of the retinal-mapping program in age-related macular degeneration. Br J Ophthalmol 2008, 92:933-935.
140. Krebs I., Hagen S., Smretschnig E., et al. Conversion of Stratus optical coherence tomography (OCT) retinal thickness to Cirrus OCT values in age-related macular degeneration. Br J Ophthalmol 2011, 95:1552-1554.
141. Lafaut B.A., Bartz-Schmidt K.U., Vanden Broecke C., et al. Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation. Br J Ophthalmol 2000, 84:239-243.
142. Lalwani G., Rosenfeld P., Fung A., et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol 2009, 148:43-58.
143. Landa G, Su E, Garcia PM, et al. Inner segment-outer segment junctional layer integrity and corresponding retinal sensitivity in dry and wet forms of age-related macular degeneration. Retina. 31:364-70.
144. Lee S., Lee C., Koh H. Posterior vitreomacular adhesion and risk of exudative age-related macular degeneration: paired eye study. Am J Ophthalmol 2009, 147:621-626.
145. Lee S.J., Koh H.J. Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration. Ophthalmology 2011, 118:101-110.
146. Legarreta J.E., Gregori G., Knighton R.W., et al. Three-dimensional spectral-domain optical coherence tomography images of the retina in the presence of epiretinal membranes. Am J Ophthalmol 2008, 145:1023-1030.
147. Leitritz M., Gelisken F., Inhoffen W., et al. Can the risk of retinal pigment epithelium tears after bevacizumab treatment be predicted? An optical coherence tomography study. Eye 2008, 22:1504-1507.
148. Leng T., Rosenfeld P.J., Gregori G., et al. Spectral domain optical coherence tomography characteristics of cuticular drusen. Retina 2009, 29:988-993.
149. Liakopoulos S., Ongchin S., Bansal A., et al. Quantitative optical coherence tomography findings in various subtypes of neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2008, 115:347-354.
150. Lima L.H., Freund K.B., Klancnik J.M., et al. Intraretinal crystalline deposits in neovascular age-related macular degeneration. Retina 2010, 30:542-547.
151. Lopez P.F., Green W.R. Peripapillary subretinal neovascularization. A review. Retina 1992, 12:147-171.
152. Lujan B., Roorda A., Knighton R.W., et al. Revealing Henle's fiber layer using spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 2011, 52:1486-1492.
153. Lujan B.J., Rosenfeld P.J., Gregori G., et al. Spectral domain optical coherence tomographic imaging of geographic atrophy. Ophthalmic Surg Lasers Imaging 2009, 40:96-101.
154. Lumbroso B., Savastano M.C., Rispoli M., et al. Morphologic differences, according to etiology, in pigment epithelial detachments by means of en face optical coherence tomography. Retina 2011, 31:553-558.
155. Malamos P., Ahlers C., Mylonas G., et al. Evaluation of segmentation procedures using spectral domain optical coherence tomography in exudative age-related macular degeneration. Retina 2011, 31:453-463.
156. Malamos P., Sacu S., Georgopoulos M., et al. Correlation of high-definition optical coherence tomography and fluorescein angiography imaging in neovascular macular degeneration. Invest Ophthalmol Vis Sci 2009, 50:4926-4933.
157. Mantel I., Uffer S., Zografos L. Peripheral exudative hemorrhagic chorioretinopathy: a clinical, angiographic, and histologic study. Am J Ophthalmol 2009, 148:932-938.
158. Margolis R., Spaide R.F. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 2009, 147:811-815.
159. Martin D.F., Maguire M.G., Ying G.S., et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Eng J Med 2011, 364:1897-1908.
160. Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology. 117:1792-9.
161. Maruko I., Iida T., Sugano Y., et al. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina 2011, 31:510-517.
162. Menard C., Cohen S.Y., Perrenoud F., et al. [Idiopathic and secondary chorioretinal folds]. J Fr Ophtalmol 1992, 15:497-502.
163. Michels S., Pircher M., Geitzenauer W., et al. Value of polarisation-sensitive optical coherence tomography in diseases affecting the retinal pigment epithelium. Br J Ophthalmol 2008, 92:204-209.
164. Mimoun G., Soubrane G., Coscas G. [Macular drusen]. J Fr Ophtalmol 1990, 13:511-530.
165. Mirza R.G., Johnson M.W., Jampol L.M. Optical coherence tomography use in evaluation of the vitreoretinal interface: a review. Surv Ophthalmol 2007, 52:397-421.
166. Mitchell P., Korobelnik J.-F., Lanzetta P., et al. Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials. Br J Ophthalmol 2010, 94:2-13.
167. Miura M., Yamanari M., Iwasaki T., et al. Imaging polarimetry in age-related macular degeneration. Invest Ophthalmol Vis Sci 2008, 49:2661-2667.
168. Mojana F., Cheng L., Bartsch D.-U.G., et al. The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results. Am J Ophthalmol 2008, 146:218-227.
169. Monson D.M., Smith J.R., Klein M.L., et al. Clinicopathologic correlation of retinal angiomatous proliferation. Arch Ophthalmol 2008, 126:1664-1668.
170. Moutray T., Alarbi M., Mahon G., et al. Relationships between clinical measures of visual function, fluorescein angiographic and optical coherence tomography features in patients with subfoveal choroidal neovascularisation. Br J Ophthalmol 2008, 92:361-364.
171. Mujat M., Ferguson R.D., Patel A.H., et al. High resolution multimodal clinical ophthalmic imaging system. Opt Express 2010, 18:11607-11621.
172. Nomura Y., Ueta T., Iriyama A., et al. Vitreomacular interface in typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy. Ophthalmology 2011, 118:853-859.
173. Novotny H.R., Alvis D.L. A method of photographing fluorescence in circulating blood in the human retina. Circulation 1961, 24:82-86.
174. Oishi A., Hata M., Shimozono M., et al. The significance of external limiting membrane status for visual acuity in age-related macular degeneration. Am J Ophthalmol 2010, 150:27-32.
175. Ojima Y., Hangai M., Sakamoto A., et al. Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography. Retina 2009, 29:52-59.
176. Otani T., Yamaguchi Y., Kishi S. Improved visualization of Henle fiber layer by changing the measurement beam angle on optical coherence tomography. Retina 2011, 31:497-501.
177. Otsuji T., Takahashi K., Fukushima I., et al. Optical coherence tomographic findings of idiopathic polypoidal choroidal vasculopathy. Ophthalmic Surg Lasers 2000, 31:210-214.
178. Oubraham H., Cohen S.Y., Samimi S., et al. Inject and extend dosing versus dosing as needed: a comparative retrospective study of ranibizumab in exudative age-related macular degeneration. Retina 2011, 31:26-30.
179. Park S.S., Truong S.N., Zawadzki R.J., et al. High-resolution Fourier-domain optical coherence tomography of choroidal neovascular membranes associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 2010, 51:4200-4206.
180. Pascolini D., Mariotti S.P., Pokharel G.P., et al. 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol 2004, 11:67-115.
181. Patel P., Bunce C., Tufail A., et al. A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design. Trials 2008, 9:56.
182. Patel P.J., Browning A.C., Chen F.K., et al. Interobserver agreement for the detection of optical coherence tomography features of neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2009, 50:5405-5410.
183. Patel P.J., Chen F.K., da Cruz L., et al. Segmentation error in Stratus optical coherence tomography for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2009, 50:399-404.
184. Pece A., Vitale L., Milani P., et al. Spontaneous reattachment of the margins of a macular retinal pigment epithelium tear: optical coherence tomography documentation of a case. Ophthalmologica 2009, 224:159-161.
185. Pieroni C.G., Witkin A.J., Ko T.H., et al. Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration. Br J Ophthalmol 2006, 90:191-197.
186. Pircher M., Götzinger E., Findl O., et al. Human macula investigated in vivo with polarization-sensitive optical coherence tomography. Invest Ophthalmol Vis Sci 2006, 47:5487-5494.
187. Povazay B., Hermann B., Hofer B., et al. Wide field optical coherence tomography of the choroid in vivo. Invest Ophthalmol Vis Sci 2008, 1856-1863.
188. Querques G., Atmani K., Berboucha E., et al. Angiographic analysis of retinal-choroidal anastomosis by confocal scanning laser ophthalmoscopy technology and corresponding (eye-tracked) spectral-domain optical coherence tomography. Retina 2010, 30:222-234.
189. Querques G, Forte R, Berboucha E, et al. Spectral-domain versus Time domain optical coherence tomography before and after ranibizumab for age-related macular degeneration. Ophthalmic Res. 46:152-9.
190. Ray R., Stinnett S.S., Jaffe G.J. Evaluation of image artifact produced by optical coherence tomography of retinal pathology. Am J Ophthalmol 2005, 139:18-29.
191. Reichel E., Duker J.S., Puliafito C.A. Indocyanine green angiography and choroidal neovascularization obscured by hemorrhage. Ophthalmology 1995, 102:1871-1876.
192. Ritter M., Elledge J., Simader C., et al. Evaluation of optical coherence tomography findings in age-related macular degeneration: a reproducibility study of two independent reading centres. Br J Ophthalmol 2011, 95:381-385.
193. Robison C., Krebs I., Binder S., et al. Vitreomacular adhesion in active and end-stage age-related macular degeneration. Am J Ophthalmol 2009, 148:79-82.
194. Roquet W., Roudot-Thoraval F., Coscas G., et al. Clinical features of drusenoid pigment epithelial detachment in age related macular degeneration. Br J Ophthalmol 2004, 88:638-642.
195. Rosenfeld P.J., Brown D.M., Heier J.S., et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006, 355:1419-1431.
196. Rotsos T., Sagoo M.S., Dacruz L., et al. Intravitreal anti-VEGF treatment in eyes with combined choroidal neovascularisation and vitreomacular traction syndrome. Br J Ophthalmol 2010, 94:1205-1210.
197. Rudolf M., Malek G., Messinger J.D., et al. Sub-retinal drusenoid deposits in human retina: organization and composition. Exp Eye Res 2008, 87:402-408.
198. Russell S.R., Mullins R.F., Schneider B.L., et al. Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration. Am J Ophthalmol 2000, 129:205-214.
199. Schuman J.S., Puliafito C.A., Fujimoto J.G. Optical Coherence Tomography of Ocular Diseases 2004, Slack Inc., Thorofare, NJ. ed 2.
200. Sadda S., Liakopoulos S., Keane P., et al. Relationship between angiographic and optical coherence tomographic (OCT) parameters for quantifying choroidal neovascular lesions. Graefes Arch Clin Exp Ophthalmol 2010, 248:175-184.
201. Sadda S.R., Joeres S., Wu Z., et al. Error correction and quantitative subanalysis of optical coherence tomography data using computer-assisted grading. Invest Ophthalmol Vis Sci 2007, 48:839-848.
202. Sadda S.R., Stoller G., Boyer D.S., et al. Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study. Retina 2010, 30:1390-1399.
203. Sadda S.R., Wu Z., Walsh A.C., et al. Errors in retinal thickness measurements obtained by optical coherence tomography. Ophthalmology 2006, 113:285-293.
204. Saito M., Iida T., Nagayama D. Cross-sectional and en face optical coherence tomographic features of polypoidal choroidal vasculopathy. Retina 2008, 28:459-464.
205. Sakamoto A., Hangai M., Yoshimura N. Spectral-domain optical coherence tomography with multiple B-scan averaging for enhanced imaging of retinal diseases. Ophthalmology 2008, 115:1071-1078.
206. Sandhu S.S., Talks S.J. Correlation of optical coherence tomography, with or without additional colour fundus photography, with stereo fundus fluorescein angiography in diagnosing choroidal neovascular membranes. Br J Ophthalmol 2005, 89:967-970.
207. Sarraf D., Reddy S., Chiang A., Yu F., Jain A. A new grading system for retinal pigment epithelial tears. Retina 2010, 30:1039-1045.
208. Sato T., Iida T., Hagimura N., et al. Correlation of optical coherence tomography with angiography in retinal pigment epithelial detachment associated with age-related macular degeneration. Retina 2004, 24:910-914.
209. Sato T., Kishi S., Watanabe G., et al. Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy. Retina 2007, 27:589-594.
210. Sayanagi K., Sharma S., Kaiser P.K. Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration. Br J Ophthalmol 2009, 93:622-626.
211. Schlanitz F.G., Ahlers C., Sacu S., et al. Performance of drusen detection by spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2010, 51:6715-6721.
212. Schmidt-Erfurth U., Leitgeb R.A., Michels S., et al. Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases. Invest Ophthalmol Vis Sci 2005, 46:3393-3402.
213. Schmidt-Erfurth U.M., Pruente C. Management of neovascular age-related macular degeneration. Prog Retin Eye Res 2007, 26:437-451.
214. Schmitz-Valckenberg S., Fleckenstein M., Gobel A.P., et al. Optical coherence tomography and autofluorescence findings in areas with geographic atrophy due to age-related macular degeneration. Invest Ophthalmol Vis Sci 2011, 52:1-6.
215. Schmitz-Valckenberg S., Fleckenstein M., Helb H.-M., et al. In vivo imaging of foveal sparing in geographic atrophy secondary to age-related macular degeneration. Invest Ophthalmol Vis Sci 2009, 50:3915-3921.
216. Schmitz-Valckenberg S., Steinberg J.S., Fleckenstein M., et al. Combined confocal scanning laser ophthalmoscopy and spectral-domain optical coherence tomography imaging of reticular drusen associated with age-related macular degeneration. Ophthalmology 2010, 117:1169-1176.
217. Schuman S., Koreishi A., Farsiu S., et al. Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography. Ophthalmology 2009, 116:488-496.
218. Schütze C., Ahlers C., Sacu S., et al. Performance of OCT segmentation procedures to assess morphology and extension in geographic atrophy. Acta Ophthalmologica 2011, 89:235-240.
219. Shah A., Del Priore L. Natural history of predominantly classic, minimally classic, and occult subgroups in exudative age-related macular degeneration. Ophthalmology 2009, 116:1901-1907.
220. Shields C.L., Salazar P.F., Mashayekhi A., et al. Peripheral exudative hemorrhagic chorioretinopathy simulating choroidal melanoma in 173 eyes. Ophthalmology 2009, 116:529-535.
221. Sikorski B.L., Bukowska D., Kaluzny J.J., et al. Drusen with accompanying fluid underneath the sensory retina. Ophthalmology 2011, 118:82-92.
222. Smith R.T., Sohrab M.A., Busuioc M., et al. Reticular macular disease. Am J Ophthalmol 2009, 148:733-743.
223. Spaide R.F. Age-related choroidal atrophy. Am J Ophthalmol 2009, 147:801-810.
224. Spaide R.F. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol 2009, 147:644-652.
225. Spaide R.F., Curcio C.A. Drusen characterization with multimodal imaging. Retina 2010, 30:1441-1454.
226. Spaide R.F., Koizumi H., Pozzoni M.C. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 2008, 146:496-500.
227. Spaide R.F., Laud K., Fine H.F., et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 2006, 26:383-390.
228. Spaide R.F., Yannuzzi L.A., Slakter J.S., et al. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 1995, 15:100-110.
229. Srinivasan V.J., Monson B.K., Wojtkowski M., et al. Characterization of outer retinal morphology with high-speed, ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci 2008, 49:1571-1579.
230. Srinivasan V.J., Wojtkowski M., Witkin A.J., et al. High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology 2006, 113:2054.
231. Stanga P.E., Lim J.I., Hamilton P. Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update. Ophthalmology 2003, 110:15-21. quiz 12-13.
232. Sunness J.S. The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration. Mol Vis 1999, 5:25.
233. Talks J., Koshy Z., Chatzinikolas K. Use of optical coherence tomography, fluorescein angiography and indocyanine green angiography in a screening clinic for wet age-related macular degeneration. Br J Ophthalmol 2007, 91:600-601.
234. Ting T.D., Oh M., Cox T.A., et al. Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration. Arch Ophthalmol 2002, 120:731-737.
235. Truong S.N., Alam S., Zawadzki R.J., et al. High resolution Fourier-domain optical coherence tomography of retinal angiomatous proliferation. Retina 2007, 27:915-925.
236. Tsui I., Jain A., Shah S., et al. Ultra widefield imaging of peripheral exudative hemorrhagic chorioretinopathy. Semin Ophthalmol 2009, 24:25-28.
237. Tsujikawa A., Sasahara M., Otani A., et al. Pigment epithelial detachment in polypoidal choroidal vasculopathy. Am J Ophthalmol 2007, 143:102-111.
238. Tufail A., Patel P.J., Egan C., et al. Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study. BMJ 2010, 340:c2459.
239. Vingerling J.R., Dielemans I., Hofman A., et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 1995, 102:205-210.
240. Wang Y., Bower B.A., Izatt J.A., et al. In vivo total retinal blood flow measurement by Fourier domain Doppler optical coherence tomography. J Biomed Opt 2007, 12:1-8.
241. Wang Y., Fawzi A.A., Varma R., et al. Pilot study of optical coherence tomography measurement of retinal blood flow in retinal and optic nerve diseases. Invest Ophthalmol Vis Sci 2011, 52:840-845.
242. Wang Y., Lu A., Gil-Flamer J., et al. Measurement of total blood flow in the normal human retina using Doppler Fourier-domain optical coherence tomography. Br J Ophthalmol 2009, 93:634-637.
243. Witkin A.J., Vuong L.N., Srinivasan V.J., et al. High-speed ultrahigh resolution optical coherence tomography before and after ranibizumab for age-related macular degeneration. Ophthalmology 2009, 116:956-963.
244. Wojtkowski M., Bajraszewski T., Gorczynska I., et al. Ophthalmic imaging by spectral optical coherence tomography. Am J Ophthalmol 2004, 138:412-419.
245. Wojtkowski M., Srinivasan V., Fujimoto J.G., et al. Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology 2005, 112:1734-1746.
246. Wolf-Schnurrbusch U.E.K., Enzmann V., Brinkmann C.K., et al. Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination. Invest Ophthalmol Vis Sci 2008, 49:3095-3099.
247. Wong T.Y., Wong T., Chakravarthy U., et al. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology 2008, 115:116-126.
248. Yamaguchi Y., Otani T., Kishi S. Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2007, 144:260-265.
249. Yannuzzi L.A., Negrão S., Iida T., et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001, 21:416-434.
250. Yannuzzi L.A., Ober M.D., Slakter J.S., et al. Ophthalmic fundus imaging: today and beyond. Am J Ophthalmol 2004, 137:511-524.
251. Yannuzzi L.A., Sorenson J., Spaide R.F., et al. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 1990, 10:1-8.
252. Yasuno Y., Miura M., Kawana K., et al. Visualization of sub-retinal pigment epithelium morphologies of exudative macular diseases by high-penetration optical coherence tomography. Invest Ophthalmol Vis Sci 2009, 50:405-413.
253. Yehoshua Z., Rosenfeld P.J., Gregori G., et al. Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography. Ophthalmology 2011, 118:679-686.
254. Yehoshua Z., Rosenfeld P.J., Gregori G., et al. Spectral domain optical coherence tomography imaging of dry age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2010, 41:S6-S14.
255. Yi K., Mujat M., Park B., et al. Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular age related macular degeneration. Br J Ophthalmol 2009, 93:176-181.
256. Zarbin M.A. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 2004, 122:598-614.
257. Zarbin M.A., Rosenfeld P.J. Pathway-based therapies for age-related macular degeneration: an integrated survey of emerging treatment alternatives. Retina 2011, 30:1350-1367.
258. Zayit-Soudry S., Moroz I., Loewenstein A. Retinal pigment epithelial detachment. Surv Ophthalmol 2007, 52:227-243.
259. Zweifel S., Spaide R., Curcio C., et al. Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology 2010, 117:303-312.
260. Zweifel S.A., Engelbert M., Laud K., et al. Outer retinal tubulation: a novel optical coherence tomography finding. Arch Ophthalmol 2009, 127:1596-1602.
261. Zweifel S.A., Imamura Y., Spaide T.C., et al. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology 2010, 117:1775-1781.
262. Zweifel S.A., Spaide R.F., Yannuzzi L.A. Acquired vitelliform detachment in patients with subretinal drusenoid deposits (reticular pseudodrusen). Retina 2011, 31:229-234.